Literature DB >> 13096450

A new antibiotic, pyridomycin.

K MAEDA, H KOSAKA, Y OKAMI, H UMEZAWA.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS

Mesh：

Substances：

Year:  1953        PMID： 13096450

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  9 in total

1.  Synthesis and antimycobacterial activity of 2,1'-dihydropyridomycins.

Authors:  Oliver P Horlacher; Ruben C Hartkoorn; Stewart T Cole; Karl-Heinz Altmann
Journal:  ACS Med Chem Lett       Date:  2012-12-18       Impact factor: 4.345

2.  Identification and characterization of the pyridomycin biosynthetic gene cluster of Streptomyces pyridomyceticus NRRL B-2517.

Authors:  Tingting Huang; Yemin Wang; Jun Yin; Yanhua Du; Meifeng Tao; Jing Xu; Wenqing Chen; Shuangjun Lin; Zixin Deng
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

Review 3.  Bacterial Enoyl-Reductases: The Ever-Growing List of Fabs, Their Mechanisms and Inhibition.

Authors:  Fernanda S M Hopf; Candida D Roth; Eduardo V de Souza; Luiza Galina; Alexia M Czeczot; Pablo Machado; Luiz A Basso; Cristiano V Bizarro
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

4.  Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA.

Authors:  Ruben C Hartkoorn; Florence Pojer; Jon A Read; Helen Gingell; João Neres; Oliver P Horlacher; Karl-Heinz Altmann; Stewart T Cole
Journal:  Nat Chem Biol       Date:  2013-12-01       Impact factor: 15.040

5.  Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.

Authors:  Ming Zhang; Claudia Sala; Ruben C Hartkoorn; Neeraj Dhar; Alfonso Mendoza-Losana; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

Review 6.  New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.

Authors:  E Jeffrey North; Mary Jackson; Richard E Lee
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Characterization of Pyridomycin B Reveals the Formation of Functional Groups in Antimycobacterial Pyridomycin.

Authors:  Tingting Huang; Zihua Zhou; Maolong Wei; Lin Chen; Zhihong Xiao; Zixin Deng; Shuangjun Lin
Journal:  Appl Environ Microbiol       Date:  2022-02-02       Impact factor: 5.005

Review 8.  Tuberculosis drug discovery in the post-post-genomic era.

Authors:  Benoit Lechartier; Jan Rybniker; Alimuddin Zumla; Stewart T Cole
Journal:  EMBO Mol Med       Date:  2014-01-08       Impact factor: 12.137

9.  Towards a new tuberculosis drug: pyridomycin - nature's isoniazid.

Authors:  Ruben C Hartkoorn; Claudia Sala; João Neres; Florence Pojer; Sophie Magnet; Raju Mukherjee; Swapna Uplekar; Stefanie Boy-Röttger; Karl-Heinz Altmann; Stewart T Cole
Journal:  EMBO Mol Med       Date:  2012-09-17       Impact factor: 12.137
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.